Nephros, Inc., a commercial stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company is headquartered in South Orange, New Jersey.
| Revenue (TTM) | $18.79M |
| Gross Profit (TTM) | $11.63M |
| EBITDA | $1.28M |
| Operating Margin | 0.38% |
| Return on Equity | 12.70% |
| Return on Assets | 5.76% |
| Revenue/Share (TTM) | $1.77 |
| Book Value | $0.96 |
| Price-to-Book | 3.30 |
| Price-to-Sales (TTM) | 1.76 |
| EV/Revenue | 1.559 |
| EV/EBITDA | 21.75 |
| Quarterly Earnings Growth (YoY) | -82.40% |
| Quarterly Revenue Growth (YoY) | 22.20% |
| Shares Outstanding | $10.64M |
| Float | $9.45M |
| % Insiders | 11.32% |
| % Institutions | 49.77% |
Volatility is currently expanding